Abstract
Cerebral Astroblastomas are rare central nervous system tumours constituting 0.45-2.8% of neuroglial tumours Recent 2021 WHO classification of Brain tumours has described Astroblastoma as “other neuroepithelial tumours” with MN1 rearrangement. Because of its rare entity and indistinctive radiological and pathological features diagnosis and further management continue to remain a challenge. Ependymoma and angiocentric glioma are the most important differential diagnoses of Astroblastoma and at times pre-operative differentiation is challenging. Here we discuss the case of a 22-year-old female with features of headache and vomiting. Histopathological examination revealed Cerebral Astroblastoma MN1 altered. Post-operative imaging suggested gross total resection of the tumour and the patient was subjected to radiotherapy of 54Gy in the tumour bed. 1-year followup of the patient showed no recurrence
